Granby Family Clinic Llc Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 201 Granby Miners Rd, Granby, MO 64844 Phone: 417-472-7200 Fax: 417-472-7201 |
News Archive
HealthEdge, provider of the only modern, enterprise-class software platform for healthcare payors, today announced the availability of Benefit Predictor, a revolutionary new capability that is now a standard part of its HealthRules Payor application. This new functionality provides HealthEdge clients with a significant competitive advantage related to both transparency and customer service, as it enables them to quickly and easily answer the most complex benefit questions from their members and providers.
Vical Incorporated announced the publication in the June issue of Melanoma Research of updated data from the company's Phase 2 trial of high-dose (2 mg) Allovectin-7® in patients with metastatic melanoma. A separate article in the May issue of Expert Opinion on Biological Therapy reviewed results from the Phase 2 trial and previous clinical studies of Allovectin-7®.
Environmental disasters can affect children's health in unique ways, both physically and psychologically. In two sessions at the Pediatric Academic Societies annual meeting at the Colorado Convention Center in Denver, Colo., experts in pediatric health care from the U.S. and Japan will examine the toll of two recent disasters on children's health: the 2011 earthquake, tsunami and nuclear crisis in Japan; and the 2010 Gulf of Mexico oil spill.
NIH Acting Director Raynard Kington on Thursday during a House Appropriations Labor-HHS-Education Subcommittee hearing said that the agency might use some of the $10.4 billion it received from the economic stimulus package to fund comparative effectiveness research that includes comparisons on the cost of treatments, CQ HealthBeat reports.
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today positive topline results from the interim analysis of the ENVISION Phase 3 Study of givosiran, an investigational RNAi therapeutic targeting aminolevulinic acid synthase 1 for the treatment of acute hepatic porphyria.
› Verified 9 days ago